Reuters logo
BRIEF-Spectral provides update on FDA meeting regarding PMA submission for toraymyxin
October 31, 2017 / 12:21 PM / 18 days ago

BRIEF-Spectral provides update on FDA meeting regarding PMA submission for toraymyxin

Oct 31 (Reuters) - Spectral Medical Inc:

* Spectral provides update on FDA meeting regarding its pma submission for toraymyxin(tm)

* Spectral Medical - ‍meeting with fda consisted of discussion of issues identified by FDA for toraymyxin​ after first 100 days of review

* Spectral Medical - co committed to a timely response to fda’s questions, which is expected to occur during month of November 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below